Agency Information Collection Activities: Proposed Collection; Comment Request

<NOTICE> DEPARTMENT OF HEALTH AND HUMAN SERVICES <SUBAGY>Substance Abuse and Mental Health Services Administration</SUBAGY> <SUBJECT>Agency Information Collection Activities: Proposed Collection; Comment Request</SUBJECT> In compliance with section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 concerning opportunity for public comment on proposed collections of information, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the information collection plans, call the SAMHSA Reports Clearance Officer on (240) 276-0361. Comments are invited on: (a) whether the proposed collections of information are necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency's estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. <HD SOURCE="HD1">Proposed Project: Program Evaluation for Prevention Contract (PEPC) Evaluation (OMB No. 0930-0377)—Revision</HD> The Substance Abuse and Mental Health Services Administration's (SAMHSA) Center for Substance Abuse Prevention (CSAP) aims to complete a cross-site evaluation of SAMHSA's SPF Rx grant program. SPF Rx is designed to address nonmedical use of prescription drugs as well as opioid overdoses by raising awareness about the dangers of sharing medications and by working with pharmaceutical and medical communities on the risks of overprescribing. The SPF Rx program grantees also raise community awareness and bring activities related to prescription drug misuse prevention and education to schools, communities, parents, prescribers, and their patients. The SPF Rx program aims to promote collaboration between states, tribes, U.S. territories, and pharmaceutical and medical communities to understand the risks of overprescribing to youth ages 12-17 and adults 18 years of age and older. The program also aims to enhance capacity for, and access to, Prescription Drug Monitoring Program (PDMP) data for prevention purposes. This request for data collection includes a revision to previously approved Office of Management and Budget (OMB) instruments to allow for data collection through the end of the grant period with the FY 2021 and FY 2022 grantees. The FY 2021 cohort of grants focuses on the dangers of sharing medications; the risks of overprescribing, especially to young adults; community awareness and education; and incorporation of PDMP data into grantees' needs assessments and strategic plans. The FY 2022 cohort of grants focused on raising awareness about the risks of sharing medications, taking fake or counterfeit pills, and overprescribing. The SPF Rx program's indicators of success are reductions in opioid overdoses, reduction in prescription drug misuse and improved use of PDMP data. Data collected through the tools described in this statement will be used for the national cross-site evaluation of SAMHSA's SPF Rx program. The Program Evaluation for Prevention Control (PEPC) team will systematically collect and maintain an Annual Reporting Tool (ART) and Grantee and Community Level Outcomes data modules submitted by SPF Rx grantees through the online Data Management System (DMS), and conduct telephone interviews with SPF Rx grantees. SAMHSA is requesting approval for data collection for the SPF Rx cross-site evaluation with the following instruments: <E T="03">Annual Reporting Tool (ART)</E> —The ART is a survey instrument collected yearly to monitor state, territory, tribal entity, and community-level performance, and to evaluate the effectiveness of the SPF Rx program. This tool is completed by grantees and sub-recipient community project directors and provides process data related to funding use and effectiveness, organizational capacity, collaboration with community partners, data infrastructure, planned intervention targets, evaluation, contextual factors, and sustainability. <E T="03">Grantee-and Community-Level Outcomes Modules</E> —These modules collect data on key SPF Rx program outcomes, including opioid prescribing patterns and provider use of PDMP. Grantees will provide outcomes data at the grantee level for their state, tribal area, or jurisdiction, as well as at the community level for each of their sub-recipient communities. <E T="03">Grantee-Level Interview</E> —This qualitative interview will be administered annually to obtain information from the grantee project directors on their programs, staffing, populations of focus, infrastructure, capacity, lessons learned, and collaboration. <GPOTABLE COLS="8" OPTS="L2,nj,i1" CDEF="s25,10,12,10,10,10,10,10"> <TTITLE> Average Annualized Data Collection Burden for the PEPC Data Collection  <E T="01"> <SU>a</SU> </E> </TTITLE> <CHED H="1">Instrument</CHED> <ENT>1.5</ENT> <ENT>161</ENT> <ENT>$30.56</ENT> <ENT>$4,920.16</ENT> </ROW> <ROW RUL="n,s"> <ENT I="22"> </ENT> <ENT>1.5</ENT> <ENT>31</ENT> <ENT>50.85</ENT> <ENT>1,576.35</ENT> </ROW> <ROW> <ENT I="03">Total Burden for ART</ENT> <ENT>6,496.51</ENT> </ROW> <ROW> <ENT I="01">Grantee-Level PDMP Outcomes Module</ENT> <ENT>2.5</ENT> <ENT>52</ENT> <ENT>50.85</ENT> <ENT>2,627.25</ENT> </ROW> <ROW> <ENT I="01">Community-Level PDMP Outcomes Module</ENT> <ENT> <SU>c</SU>  21 </ENT> <ENT>5.2</ENT> <ENT>107</ENT> <ENT>1.25</ENT> <ENT>134.17</ENT> <ENT>50.85</ENT> <ENT>6,822.38</ENT> </ROW> <ROW RUL="n,s"> <ENT I="01">Grantee-Level Interview</ENT> <ENT>1.5</ENT> <ENT>31</ENT> <ENT>50.85</ENT> <ENT>1,576.35</ENT> </ROW> <ROW> <ENT I="03">Total Annualized Burden</ENT> <ENT>191</ENT> <ENT/> <ENT>277</ENT> <ENT/> <ENT>409.17</ENT> <ENT/> <ENT>17,522.49</ENT> </ROW> <TNOTE> <SU>a</SU>   <E T="03">Annualized Data Collection Burden</E> captures the average number of respondents and responses, burden hours, and respondent cost over the 3 years (FY 2026-FY 2028). </TNOTE> <TNOTE> <SU>b</SU>  Community subrecipient respondent. </TNOTE> <TNOTE> <SU>c</SU>  Grantee respondent. </TNOTE> <TNOTE> <SU>d</SU>   <E T="03">Grantee Project Director or Evaluator hourly wage</E> is based on the mean hourly wage for state government managers, as reported in the 2023 Occupational Employment (OES) by the Bureau of Labor Statistics (BLS) found at <E T="03">https://www.bls.gov/oes/current/naics4_999200.htm#11-00000.</E> </TNOTE> <TNOTE> <SU>e</SU>   <E T="03">Subrecipient Staff hourly wage</E> is based on the mean hourly wage for local government counselors, social workers, and other community and social service specialists, as reported in the 2023 OES by the BLS found at <E T="03">https://www.bls.gov/oes/current/naics4_999300.htm.</E> </TNOTE> </GPOTABLE> Send comments to SAMHSA Reports Clearance Officer, 5600 Fishers Lane, Room 15E57-A, Rockville, Maryland 20857, <E T="03">OR</E> email a copy to <E T="03">samhsapra@samhsa.hhs.gov.</E> Written comments should be received by January 20, 2026. <SIG> <NAME>Alicia Broadus,</NAME> Public Health Advisor. </SIG> <FRDOC>[FR Doc. 2025-20394 Filed 11-19-25; 8:45 am]</FRDOC> </NOTICE>